Comparison of patients with and without ASCIE
Measure . | Patients without ASCIE . | Patients with ASCIE . | P* . |
---|---|---|---|
Sex, male, no./total (%) | 23/46 (50.0) | 4/6 (66.7) | .670 |
Median age, y (range) | 9.60 (3.07-17.76) | 8.33 (5.73-11.27) | .474 |
Fever present, no./total (%) | 24/46 (52.2) | 4/6 (66.7) | .674 |
Abnormal initial neurologic examination, no./total (%) | 8/43 (18.6) | 2/5 (40) | .276 |
Abnormal follow-up neurologic examination, no./total (%) | 10/38 (26.3) | 1/4 (25) | > .999 |
Oxygen requirement, no./total (%) | 13/46 (28) | 5/6 (83.3) | .015 |
ICU admission, no./total (%) | 11/46 (23.9) | 3/6 (50) | .325 |
Transfusion, no./total (%) | 42/46 (91.3) | 6/6 (100) | > .999 |
Median minimum hemoglobin, g/dL (range) | 4.4 (2.6-5.5) | 3.1 (2.2-4.1) | .003 |
Median white blood count, ×103 (range) | 7.750 (0.1-105.5) | 11.250 (2.2-25.7) | .742 |
Median platelets, ×103 (range) | 171 (1-588) | 189 (4-601) | .626 |
Measure . | Patients without ASCIE . | Patients with ASCIE . | P* . |
---|---|---|---|
Sex, male, no./total (%) | 23/46 (50.0) | 4/6 (66.7) | .670 |
Median age, y (range) | 9.60 (3.07-17.76) | 8.33 (5.73-11.27) | .474 |
Fever present, no./total (%) | 24/46 (52.2) | 4/6 (66.7) | .674 |
Abnormal initial neurologic examination, no./total (%) | 8/43 (18.6) | 2/5 (40) | .276 |
Abnormal follow-up neurologic examination, no./total (%) | 10/38 (26.3) | 1/4 (25) | > .999 |
Oxygen requirement, no./total (%) | 13/46 (28) | 5/6 (83.3) | .015 |
ICU admission, no./total (%) | 11/46 (23.9) | 3/6 (50) | .325 |
Transfusion, no./total (%) | 42/46 (91.3) | 6/6 (100) | > .999 |
Median minimum hemoglobin, g/dL (range) | 4.4 (2.6-5.5) | 3.1 (2.2-4.1) | .003 |
Median white blood count, ×103 (range) | 7.750 (0.1-105.5) | 11.250 (2.2-25.7) | .742 |
Median platelets, ×103 (range) | 171 (1-588) | 189 (4-601) | .626 |
ASCIE indicates acute silent cerebral ischemic event; and ICU, intensive care unit.
Mann-Whitney for continuous variables; Fisher exact for categorical variables.